CBL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.558600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.444000E-01
Normal-vs-Stage2
3.741800E-01
Normal-vs-Stage3
2.148600E-01
Normal-vs-Stage4
4.146000E-01
Stage1-vs-Stage2
7.145800E-01
Stage1-vs-Stage3
1.060770E-01
Stage1-vs-Stage4
5.121800E-01
Stage2-vs-Stage3
9.842000E-02
Stage2-vs-Stage4
5.963600E-01
Stage3-vs-Stage4
1.447600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.565600E-01
Normal-vs-AfricanAmerican
3.819600E-01
Normal-vs-Asian
2.433400E-01
Caucasian-vs-AfricanAmerican
2.065800E-01
Caucasian-vs-Asian
5.319600E-02
AfricanAmerican-vs-Asian
2.463600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.527200E-01
Normal-vs-Female
3.627000E-01
Male-vs-Female
7.954600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.053200E-01
Normal-vs-Age(41-60Yrs)
4.467000E-01
Normal-vs-Age(61-80Yrs)
3.288200E-01
Normal-vs-Age(81-100Yrs)
2.763000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.751000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.494400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.067400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.036170E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.517800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.781600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.334300E-02
Normal-vs-Daily Drinker
2.907600E-01
Normal-vs-Weekly Drinker
3.040400E-01
Normal-vs-Occasional Drinker
3.352400E-01
Normal-vs-Social Drinker
1.390230E-01
Non Drinker-vs-Daily Drinker
4.236800E-01
Non Drinker-vs-Weekly Drinker
6.068400E-01
Non Drinker-vs-Occasional Drinker
9.347600E-01
Non Drinker-vs-Social Drinker
4.497400E-01
Daily Drinker-vs-Weekly Drinker
8.374600E-01
Daily Drinker-vs-Occasional Drinker
4.288400E-01
Daily Drinker-vs-Social Drinker
1.351990E-01
Weekly Drinker-vs-Occasional Drinker
5.898600E-01
Weekly Drinker-vs-Social Drinker
2.331400E-01
Occasional Drinker-vs-Social Drinker
3.721000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.287600E-01
Normal-vs-Grade 2
2.783700E-02
Normal-vs-Grade 3
3.696200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.247900E-02
Grade 1-vs-Grade 3
3.957800E-02
Grade 1-vs-Grade 4
2.287600E-01
Grade 2-vs-Grade 3
4.532400E-01
Grade 2-vs-Grade 4
2.783700E-02
Grade 3-vs-Grade 4
3.696200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.407000E-01
Normal-vs-NonDiabetic
3.310400E-01
Diabetic-vs-NonDiabetic
8.630000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.038000E-01
Normal-vs-NoPancreatitis
3.354000E-01
Pancreatitis-vs-NoPancreatitis
3.904200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.407200E-01
Normal-vs-N1
3.710800E-01
N0-vs-N1
4.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.647400E-01
Normal-vs-TP53-NonMutant
3.258000E-01
TP53-Mutant-vs-TP53-NonMutant
4.734600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
